Combined Modality Treatment for Patients With Stage IV Melanoma

Clinical trial NCT00313235 · COMPLETED

Trial details

NCT number: NCT00313235
Sponsor: Baylor Research Institute
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malignant Melanoma Stage IV

Start date: 2006-03-01
Primary completion: 2011-06-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.